It likely wasn't picked up by Big Pharma because the research was for a disease that affects a couple hundred people in the states. There's no money in that d

It likely wasn't picked up by Big Pharma because the research was for a disease that affects a couple hundred people in the states. There's no money in that disease, but if the research had been in cardiovascular disease, Big Pharma would have been all over it (which it looks like is now the case).